

Group 1 - IonQ, Inc. is considered "too speculative" and is losing significant money, according to Jim Cramer [1] - IonQ formed a strategic partnership with the Korea Institute of Science and Technology Information to advance South Korea's quantum technology goals [1] - Oklo Inc. is viewed as being "five years behind" GE Vernova, leading to a preference for GE Vernova over Oklo [1] Group 2 - Valero Energy reported first-quarter sales of $30.26 billion, exceeding analyst expectations of $28.68 billion [2] - Cramer prefers Phillips over Valero Energy, suggesting Valero has already seen too much growth [2] - Verona Pharma is described as a "rocket ship" but is also highly speculative due to significant losses and insider selling [2] Group 3 - Centrus Energy reported better-than-expected first-quarter revenue results [3] - Cramer advises caution regarding Centrus Energy, recommending GE Vernova instead [3] Group 4 - Valero Energy shares increased by 1.7% to $130.71 [4] - IONQ shares rose by 5.1% to $48.04 [4] - Verona Pharma shares gained 0.7% to $75.61 [4] - Centrus Energy shares surged by 12.9% to $127.86 [4] - Oklo shares jumped by 10.3% to $53.90 [4]